Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 2-3
221
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Serum Levels of Hepcidin in Rheumatoid Arthritis and Its Correlation with Disease Activity and Anemia: A Meta-analysis

, , , , , , , , , ORCID Icon & ORCID Icon show all

References

  • Abdel-Khalek MA, El-Barbary AM, Essa SA, Ghobashi AS. 2011. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 38(10):2153–59.
  • Andrews NC. 2004. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 113(9):1251–53.
  • Cronstein BN. 2007. Interleukin-6–a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis. 65(Suppl 1):S11–5.
  • Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, et al. 2014. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 73(7):1316–22.
  • David M, Alessandro L, Jennifer T, Douglas. 2010. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 8(5):336–41.
  • De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, Kaplan J. 2007. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 18(7):2569–78.
  • De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, et al. 2010. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 120(7):2395–405.
  • Demirag MD, Haznedaroglu S, Sancak B, Konca C, Gulbahar O, Ozturk MA, Goker B. 2009. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med. 48(6):421–26.
  • Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423(6937):356–61.
  • Flanagan JM, Truksa J, Peng H, Lee P, Beutler E. 2007. In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol Dis. 38(3):253–57.
  • Ganz T. 2003. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 102(3):783–88.
  • Ganz T. 2005. Hepcidin–a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 18(2):171–82.
  • Geerts I, Vermeersch P, Joosten E. 2012. Evaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients. ISRN Hematol. 2012(567491):1–3.
  • Goodnough LT, Nemeth E, Ganz T. 2010. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 116(23):4754–61.
  • Griffiths WJ. 2007. Review article: the genetic basis of haemochromatosis. Aliment Pharmacol Ther. 26(3):331–42.
  • Han C, Rahman MU, Doyle MK, Bathon JM, Smolen J, Kavanaugh A, Westhovens R, St Clair EW, Baker D, Bala M. 2007. Association of anemia and physical disability among patients with rheumatoid arthritis. J Rheumatol. 34(11):2177–82.
  • Hansen NE. 1983. The anaemia of chronic disorders: a bag of unsolved questions. Scand J Haematol. 31(5): 397–402.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327(7414):557–60.
  • Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, et al. 1988. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 18(11):1797–801.
  • Jayaranee S, Sthaneshwar P, Sokkalingam S. 2009. Serum prohepcidin concentrations in rheumatoid arthritis. Pathology. 41(2):178–82.
  • Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. 2005. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 106(5):1864–66.
  • Kemna EH, Tjalsma H, Willems HL, Swinkels DW. 2008. Hepcidin: from discovery to differential diagnosis. Haematologica. 93(1):90–97.
  • Kirkwood KL, Zhang L, Thiyagarajan R, Seldeen KL, Troen BR. 2018. Myeloid-derived suppressor cells at the intersection of inflammaging and bone fragility. Immunol Invest. 47(8):844–54.
  • Koca SS, Ateş O, Üstündağ B, ÇELİKER Ü, Özgen M, Işik A. 2008a. Serum prohepcidin level in Behçet’s disease. Turkiye Klinikleri Journal of Medical Sciences. 28(5):601–05.
  • Koca SS, Isik A, Ustundag B, Metin K, Aksoy K. 2008b. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation. 31(3):146–53.
  • Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480(2–3):147–50.
  • Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W. 2004. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 53(5):735–43.
  • Manolov V, Paskaleva-Peycheva V, Velizarova M, Atanasova B, Hadjidekova S, Tzatchev K, Bogov I, Genchev GGrozdanova R. 2014. New tools in diagnosis of anemia in rheumatoid arthritis. International Journal of Development Research. 4(12):2743–45.
  • Means RT Jr. 2004. Hepcidin and anaemia. Blood Rev. 18(4):219–25.
  • Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. 2014. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 20(2):123–29.
  • Moller B, Scherer A, Forger F, Villiger PM, Finckh A. 2014. Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Ann Rheum Dis. 73(4):691–96.
  • Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. 2004a. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 113(9):1271–76.
  • Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004b. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 306(5704):2090–93.
  • Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 101(7):2461–63.
  • Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 110(7):1037–44.
  • Ostgard RD, Glerup H, Jurik AG, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Horslev-Petersen K, Junker P, Deleuran BW. 2017. Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients. Scand J Rheumatol. 46(6):441–45.
  • Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, Silvestri L. 2011. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood. 118(3):736–46.
  • Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 276(11):7806–10.
  • Peeters HR, Jongen-Lavrencic M, Raja AN, Ramdin HS, Vreugdenhil G, Breedveld FC, Swaak AJ. 1996. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis. 55(3):162–68.
  • Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 276(11):7811–19.
  • Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 33(1):21–22.
  • Sabău A, Văleanu M, Boloşiu HDCrăciun AM. 2013. Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity. Romanian Review of Laboratory Medicine. 21(1):17–27.
  • Sahebari M, Rezaieyazdi Z, Hashemy SI, Khorasani S, Shahgordi S, Alizadeh MK, Ghaeni A, Khodashahi M. 2018. Serum hepcidin level and rheumatoid arthritis disease activity. Eur J Rheumatol. 6(2):76–80.
  • Scholz GA, Leichtle AB, Scherer A, Arndt U, Fiedler M, Aeberli D, Finckh A, Gabay C, Kyburz DVilliger PM. 2019. The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. Br J Haematol. 186(1):101–12.
  • Sellam J, Kotti S, Fellahi S, Bastard JP, Meyer M, Liote F, Meyer O, Simon T, Capeau J, Berenbaum F. 2013. Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 72(2):312–14.
  • Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RV, Simitchiev KK. 2016. Pathobiochemical mechanisms relating iron homeostasis to parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 58(4):257–63.
  • Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RVSimitchiev KK. 2018. Pathobiochemical mechanisms relating iron homeostasis with parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 58(4):257–63.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 283(15):2008–12.
  • Taghadosi M, Samimi Z, Assar S, Salahshoor MR, Jalili C. 2020. Plasma leptin does not reflect the effect of high body mass index on disease activity in rheumatoid arthritis. Immunol Invest. 49(1–2):32–45.
  • Teke HU, Cansu DU, Yildiz P, Temiz G, Bal C. 2017. Clinical significance of serum IL-6, TNF-α, hepcidin, and EPO levels in anaemia of chronic disease and iron deficiency anaemia: the laboratory indicators for anaemia. Biomedical Research. 28:2704–10.
  • van Steenbergen HW, van Nies JA, van der Helm-van Mil AH. 2013. Anaemia to predict radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 72(7):e16.
  • Vreugdenhil G, Baltus JA, van Eijk HG, Swaak AJ. 1989. Prediction and evaluation of the effect of iron treatment in anaemic RA patients. Clin Rheumatol. 8(3):352–62.
  • Wahle M. 2012. [Anemia in patients with rheumatoid arthritis.]. Zeitschrift Für Rheumatologie. 71(10):864–68.
  • Wan X, Wang W, Liu J, Tong T. 2014. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 14:135.
  • Wrighting DM, Andrews NC. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood. 108(9):3204–09.
  • Wu XD, Zhang Z, Chen Y, Xie BH, Gan MZ, Huang XQLiu L. 2013. Association of serum bone morphogenetic protein-6 and hepcidin levels with anemia in patients with rheumatoid arthritis. Zhejiang Medical Journal. 35(18):1632–36.
  • Young A, Koduri G. 2007. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 21(5):907–27.
  • Yunt ZX, Solomon JJ. 2015. Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am. 41(2):225–36.
  • Zeng T, Song CY, Shi DGu KF. 2015. Significance of hepcidin in patients with rheumatoid arthritis. Chinese Journal of Difficult and Complicated Cases. 14(1):33–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.